What is the market cap for Novo-Nordisk A/S (NVO) stock?

The market cap for Novo-Nordisk A/S (NVO) stock is approximately US$206.69B.

What is the P/E ratio for Novo-Nordisk A/S (NVO) stock?

The price-to-earnings ratio for Novo-Nordisk A/S (NVO) is 12.80, based on the latest reported earnings.

What is the 52-week high for Novo-Nordisk A/S (NVO) stock?

The 52-week high for Novo-Nordisk A/S (NVO) stock is US$64.16.

What is the 52-week low for Novo-Nordisk A/S (NVO) stock?

The 52-week low for Novo-Nordisk A/S (NVO) stock is US$35.12.

Does Novo-Nordisk A/S (NVO) pay dividends?

Yes, Novo-Nordisk A/S (NVO) pays a dividend. The trailing 12-month dividend yield is 0.94%.

Trade NVO stock anytime, 24x5 in Singapore

$0* Commission

$0 Platform fee

Regulated by

Monetary Authority of Singapore (MAS)

Trusted by

400,000+ users

NVOUS

Novo-Nordisk A/S (NVO) Stock Price

Overview

Novo-Nordisk A/S (NVO) is trading at US$43.24, up 0.12% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$206.69B. Over the past 52 weeks, NVO has traded between US$35.12 and US$64.16. On Syfe you can trade NVO with $0 commission and add it to your watchlist.

Key Statistics

Previous close	US$43.19
Market cap	US$206.69B
P/E ratio	12.80
52-week range	US$35.12 – US$64.16
Dividend yield	0.94%
Volume	10.33M
Exchange	US

Add to Watchlist

Set Price Alert

About

NVOUS

Novo-Nordisk A/S

US Stocks

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Year: 1981